ZYBTNasdaqPharmaceutical Preparations
Zhengye Biotechnology Holding Ltd
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 28, 2026
$1.45+0.05 (+3.57%)
Close on Oct 19, 2026
Ownership
Who owns Zhengye Biotechnology's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Securingium Holding Limited | 42,963,748 | 90.66% | 13G (passive) | Dec 31, 2024 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Songlin Song | Co-Chief Executive Officer | – | – | Jun 25, 2026 |
| Yuhong (nmn) Cheng | Vice General Manager | – | – | Jun 25, 2026 |
| Ping (nmn) Wang | Chief Financial Officer | – | – | Jun 25, 2026 |
| Aiden Han | Co-Chief Executive Officer | – | – | Mar 18, 2026 |
| Wei Lian | Vice General Manager | – | – | Mar 18, 2026 |
| Zhongyao Liu | Chief Operating Officer | – | – | Mar 18, 2026 |
| Ping (PiJi) Jiang | Director | – | – | Jun 25, 2026 |
| Zhenfa Han | Director, 10% owner | 42,963,748 | 90.66% | Jun 25, 2026 |
| Qiyi Hu | Director | – | – | Apr 24, 2026 |
| Guohan (nmn) Li | Director | – | – | Apr 24, 2026 |
| Wenhua Sun | Director | – | – | Mar 18, 2026 |
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Skyline Holdings Limited Vanguards Shareholder | Oct 22, 2025 | 2,278,752 | $29.42M | Nov 1, 2025 | Purchase |
| Holdings Limited VVAX Shareholder | Oct 22, 2025 | 684,996 | $1.79M | Nov 1, 2025 | Purchase |